Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
1983 1
1984 1
1987 1
1988 5
1989 4
1990 13
1991 5
1992 7
1993 6
1994 4
1995 5
1996 4
1997 3
1998 3
1999 5
2000 1
2001 6
2002 4
2003 6
2004 1
2005 3
2006 3
2007 1
2008 1
2010 1
2012 3
2013 2
2014 6
2015 8
2016 5
2017 3
2018 2
2019 1
2020 2
2021 1
2022 4
Text availability
Article attribute
Article type
Publication date

Search Results

126 results
Results by year
Filters applied: . Clear all
Page 1
FDG PET-CT for solitary pulmonary nodule and lung cancer: Literature review.
Groheux D, Quere G, Blanc E, Lemarignier C, Vercellino L, de Margerie-Mellon C, Merlet P, Querellou S. Groheux D, et al. Among authors: merlet p. Diagn Interv Imaging. 2016 Oct;97(10):1003-1017. doi: 10.1016/j.diii.2016.06.020. Epub 2016 Aug 24. Diagn Interv Imaging. 2016. PMID: 27567555 Free article. Review.
Predictive factors of early progression after CAR T-cell therapy in relapsed/refractory diffuse large B-cell lymphoma.
Vercellino L, Di Blasi R, Kanoun S, Tessoulin B, Rossi C, D'Aveni-Piney M, Obéric L, Bodet-Milin C, Bories P, Olivier P, Lafon I, Berriolo-Riedinger A, Galli E, Bernard S, Rubio MT, Bossard C, Meignin V, Merlet P, Feugier P, Le Gouill S, Ysebaert L, Casasnovas O, Meignan M, Chevret S, Thieblemont C. Vercellino L, et al. Among authors: merlet p. Blood Adv. 2020 Nov 24;4(22):5607-5615. doi: 10.1182/bloodadvances.2020003001. Blood Adv. 2020. PMID: 33180899 Free PMC article.
Imaging inflammatory cardiomyopathies.
Le Guludec D, Sarda L, Rouzet F, Merlet P, Slama MS, Lebtahi R. Le Guludec D, et al. Among authors: merlet p. J Nucl Cardiol. 2005 Nov-Dec;12(6):731-9. doi: 10.1016/j.nuclcard.2005.09.005. J Nucl Cardiol. 2005. PMID: 16344235 Review. No abstract available.
[Aldosterone and its antagonists in heart failure].
Lopes ME, Le Corvoisier P, Tabet JY, Su JB, Badoual T, Cachin JC, Merlet P, Castaigne A, Hittinger L. Lopes ME, et al. Among authors: merlet p. Presse Med. 2003 Jan 18;32(2):79-87. Presse Med. 2003. PMID: 12653034 Review. French.
BCL-2 Inhibitor ABT-737 Effectively Targets Leukemia-Initiating Cells with Differential Regulation of Relevant Genes Leading to Extended Survival in a NRAS/BCL-2 Mouse Model of High Risk-Myelodysplastic Syndrome.
Gorombei P, Guidez F, Ganesan S, Chiquet M, Pellagatti A, Goursaud L, Tekin N, Beurlet S, Patel S, Guerenne L, Le Pogam C, Setterblad N, de la Grange P, LeBoeuf C, Janin A, Noguera ME, Sarda-Mantel L, Merlet P, Boultwood J, Konopleva M, Andreeff M, West R, Pla M, Adès L, Fenaux P, Krief P, Chomienne C, Omidvar N, Padua RA. Gorombei P, et al. Among authors: merlet p. Int J Mol Sci. 2021 Sep 30;22(19):10658. doi: 10.3390/ijms221910658. Int J Mol Sci. 2021. PMID: 34638998 Free PMC article.
Intermittent Versus Continuous Dosing of MAPK Inhibitors in the Treatment of BRAF-Mutated Melanoma.
Reger de Moura C, Vercellino L, Jouenne F, Baroudjian B, Sadoux A, Louveau B, Delyon J, Serror K, Goldwirt L, Merlet P, Bouquet F, Battistella M, Lebbé C, Mourah S. Reger de Moura C, et al. Among authors: merlet p. Transl Oncol. 2020 Feb;13(2):275-286. doi: 10.1016/j.tranon.2019.10.003. Epub 2019 Dec 23. Transl Oncol. 2020. PMID: 31874374 Free PMC article.
[Pre-hospital thrombolysis].
Castaigne A, Hervé C, Duval-Moulin AM, Dubois-Randé JL, Merlet P, Hittinger L. Castaigne A, et al. Among authors: merlet p. Arch Mal Coeur Vaiss. 1990 Feb;83 Spec No 1:41-5. Arch Mal Coeur Vaiss. 1990. PMID: 2108646 Clinical Trial. French.
¹⁸F-FDG PET/CT for the Early Evaluation of Response to Neoadjuvant Treatment in Triple-Negative Breast Cancer: Influence of the Chemotherapy Regimen.
Groheux D, Biard L, Giacchetti S, Teixeira L, Hindié E, Cuvier C, Vercellino L, Merlet P, de Roquancourt A, de Cremoux P, Resche-Rigon M, Espié M. Groheux D, et al. Among authors: merlet p. J Nucl Med. 2016 Apr;57(4):536-43. doi: 10.2967/jnumed.115.163907. Epub 2015 Dec 23. J Nucl Med. 2016. PMID: 26697967 Free article.
126 results